Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Author:
- R.J. ArceciRAR.J. Arceci
- 1 January 2010
- journal article
- Published by Elsevier in Yearbook of Oncology
- Vol. 2010, 125-126
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: